Influenza
Showing NaN - NaN of 60
Influenza Trial in United States (Flublok Quadrivalent Influenza Vaccine, Inactivated Influenza Vaccine)
Completed
- Influenza
- Flublok Quadrivalent Influenza Vaccine
- Inactivated Influenza Vaccine
-
Mobile, Alabama
- +37 more
Sep 26, 2017
Influenza Trial in United States (GSK Biologicals' investigational vaccine GSK2590066A, GSK Biologicals' investigational vaccine
Completed
- Influenza
- GSK Biologicals' investigational vaccine GSK2590066A
- +4 more
-
Anaheim, California
- +3 more
May 9, 2017
Influenza Trial in Canada, United States (Investigational H7N1 vaccine GSK2789869A, Investigational H7N1 vaccine GSK2789868A,
Completed
- Influenza
- Investigational H7N1 vaccine GSK2789869A
- +2 more
-
Miami, Florida
- +8 more
May 4, 2017
Influenza Trial in United States (Flublok Quadrivalent, Inactivated Influenza Vaccine (IIV4))
Completed
- Influenza
- Flublok Quadrivalent
- Inactivated Influenza Vaccine (IIV4)
-
Sacramento, California
- +9 more
Sep 22, 2016
Influenza Trial in Finland, United States (Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV), non-adjuvanted
Completed
- Influenza
- Adjuvanted Quadrivalent Subunit Influenza Virus Vaccine (aQIV)
- non-adjuvanted Quadrivalent Influenza Vaccine (QIV)
-
San Diego, California
- +27 more
Oct 26, 2016
Influenza Trial in United States (Influenza vaccine (A/H3N2, A/H1N1, and B strains), Fluarix)
Completed
- Influenza
- Influenza vaccine (A/H3N2, A/H1N1, and B strains)
- Fluarix
-
Miami, Florida
- +5 more
Oct 6, 2016
Influenza Trial in Puerto Rico, United States (Influenza Virus Vaccine USP Trivalent Types A and B)
Completed
- Influenza
- Influenza Virus Vaccine USP Trivalent Types A and B
-
Hoover, Alabama
- +44 more
Apr 12, 2016
Influenza, Swine-origin A/H1N1 Influenza Trial in United States (Monovalent Subvirion A/H1N1 Influenza vaccine, Normal saline
Completed
- Influenza
- Swine-origin A/H1N1 Influenza
- Monovalent Subvirion A/H1N1 Influenza vaccine
- Normal saline solution (placebo)
-
Miami Beach, Florida
- +19 more
Apr 12, 2016
Novel Influenza A (H1N1) Surveillance Registry
Completed
- Novel Influenza A
- +2 more
-
Anchorage, Alaska
- +85 more
Apr 13, 2016
Orthomyxoviridae Infection, Influenza, Myxovirus Infection Trial in Puerto Rico, United States (Influenza Virus Vaccine USP
Completed
- Orthomyxoviridae Infection
- +2 more
- Influenza Virus Vaccine USP Trivalent Types A and B
-
Hoover, Alabama
- +48 more
Apr 12, 2016
Influenza Trial in Worldwide (Favipiravir, Placebo comparator)
Influenza Trial in United States (Vero cell-derived, trivalent, seasonal influenza vaccine, Placebo: Phosphate-buffered saline)
Completed
- Influenza
- Vero cell-derived, trivalent, seasonal influenza vaccine
- Placebo: Phosphate-buffered saline
-
Tucson, Arizona
- +35 more
Oct 7, 2015
Influenza Trial in United States (Vero cell derived, trivalent, seasonal influenza vaccine, Licensed egg-derived, trivalent
Completed
- Influenza
- Vero cell derived, trivalent, seasonal influenza vaccine
- Licensed egg-derived, trivalent seasonal influenza vaccine
-
Mobile, Alabama
- +29 more
Oct 7, 2015
Influenza Trial in United States (Licensed 2010-2011 Trivalent Influenza Vaccine, No Preservative, Investigational Trivalent
Completed
- Influenza
- Licensed 2010-2011 Trivalent Influenza Vaccine, No Preservative
- +2 more
-
Dothan, Alabama
- +66 more
Jun 16, 2015
Influenza Trial in United States (Influenza Virus Vaccine USP Quadrivalent, (Zonal Purified Subvirion) 2012 2013 Formulation,
Completed
- Influenza
- Influenza Virus Vaccine USP Quadrivalent, (Zonal Purified Subvirion) 2012 2013 Formulation
- +2 more
-
Hoover, Alabama
- +37 more
Apr 20, 2015
Influenza Trial in United States (VAX2012Q)
Unknown status
- Influenza
- VAX2012Q
-
Lenexa, Kansas
- +3 more
Mar 5, 2015
Influenza Trial in United States (Vero cell-derived trivalent influenza vaccine manufactured with the modified manufacturing
Completed
- Influenza
- Vero cell-derived trivalent influenza vaccine manufactured with the modified manufacturing process (VCIV modified)
- +2 more
-
Chandler, Arizona
- +19 more
Jun 27, 2014